WALTHAM, Mass., July 27, 2016 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that it received a U.S. Department of Justice subpoena addressed to Alere Toxicology Services, Inc. on July 1, 2016. The subpoena seeks records related to Medicare, Medicaid and Tricare billings dating back to 2010 for patient samples tested at the Company's Austin, Texas pain management laboratory. The Company is fully cooperating with the investigation.
For the first nine months of 2015, Medicare, Medicaid and Tricare billings at the Austin pain management laboratory accounted for significantly less than 1% of Alere's total revenues.
Alere believes the matters to which the subpoena relates are not material.
Alere believes that when diagnosing and monitoring health conditions, Knowing now matters.™ Alere delivers reliable and actionable information by providing rapid diagnostic tests, enhancing clinical and economic healthcare outcomes globally. Headquartered in Waltham, Mass., Alere focuses on rapid diagnostics for cardiometabolic disease, infectious disease and toxicology. For more information on Alere, please visit www.alere.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/alere-comments-on-pain-management-subpoena-300305230.html
SOURCE Alere Inc.